The Medical clinics of North AmericaHumansHeart FailureMineralocorticoid Receptor AntagonistsAdrenergic beta-AntagonistsSodium-Glucose Transporter 2 Inhibitors
Heart Failure Pharmacotherapy.
Dusty L Lisi, Kira Gaddis, Mahmoud H Abdou
Published: 202510.1016/j.mcna.2025.04.003
Abstract
Pharmacotherapy for heart failure (HF) with reduced ejection fraction (HFrEF) is the foundation of management. The basis of pharmacotherapy for HFrEF includes 4 pillars: beta-blockers, renin angiotensin aldosterone system modulators, mineralocorticoi…
Preview only. Read the full abstract at the source